These findings suggest that CCRK functions as a major signaling hub in obesity-associated hepatocarcinogenesis, providing insights into therapeutic strategies to reduce tumor burden from the worldwide obesity epidemic. This evidence concerns the gene CDK20 and obesity disorder.